Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Baxter
Teva
Fuji
Federal Trade Commission
UBS
Deloitte
QuintilesIMS

Generated: May 26, 2018

DrugPatentWatch Database Preview

FENTANYL-37 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Fentanyl-37, and when can generic versions of Fentanyl-37 launch?

Fentanyl-37 is a drug marketed by Aveva and Mylan Technologies and is included in two NDAs.

The generic ingredient in FENTANYL-37 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Summary for FENTANYL-37
Drug patent expirations by year for FENTANYL-37
Pharmacology for FENTANYL-37
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for FENTANYL-37

US Patents and Regulatory Information for FENTANYL-37

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aveva FENTANYL-37 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077449-006 Dec 6, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Technologies FENTANYL-37 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076258-006 Dec 29, 2014 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Julphar
Harvard Business School
US Army
QuintilesIMS
Boehringer Ingelheim
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.